Genome Medicine (May 2023)
Correction: Acetyl-CoA metabolism drives epigenome change and contributes to carcinogenesis risk in fatty liver disease
- Gabriella Assante,
- Sriram Chandrasekaran,
- Stanley Ng,
- Aikaterini Tourna,
- Carolina H. Chung,
- Kowsar A. Isse,
- Jasmine L. Banks,
- Ugo Soffientini,
- Celine Filippi,
- Anil Dhawan,
- Mo Liu,
- Steven G. Rozen,
- Matthew Hoare,
- Peter Campbell,
- J. William O. Ballard,
- Nigel Turner,
- Margaret J. Morris,
- Shilpa Chokshi,
- Neil A. Youngson
Affiliations
- Gabriella Assante
- Institute of Hepatology, Foundation for Liver Research
- Sriram Chandrasekaran
- Program in Chemical Biology, University of Michigan
- Stanley Ng
- Wellcome Trust Sanger Institute
- Aikaterini Tourna
- Institute of Hepatology, Foundation for Liver Research
- Carolina H. Chung
- Department of Biomedical Engineering, University of Michigan
- Kowsar A. Isse
- Institute of Hepatology, Foundation for Liver Research
- Jasmine L. Banks
- UNSW Sydney
- Ugo Soffientini
- Institute of Hepatology, Foundation for Liver Research
- Celine Filippi
- Institute of Liver Studies, King’s College Hospital
- Anil Dhawan
- Institute of Liver Studies, King’s College Hospital
- Mo Liu
- Programme in Cancer and Stem Cell Biology, Duke-NUS Medical School
- Steven G. Rozen
- Programme in Cancer and Stem Cell Biology, Duke-NUS Medical School
- Matthew Hoare
- CRUK Cambridge Institute
- Peter Campbell
- Wellcome Trust Sanger Institute
- J. William O. Ballard
- Department of Ecology, Environment and Evolution, La Trobe University
- Nigel Turner
- UNSW Sydney
- Margaret J. Morris
- UNSW Sydney
- Shilpa Chokshi
- Institute of Hepatology, Foundation for Liver Research
- Neil A. Youngson
- Institute of Hepatology, Foundation for Liver Research
- DOI
- https://doi.org/10.1186/s13073-023-01190-7
- Journal volume & issue
-
Vol. 15,
no. 1
pp. 1 – 1
Abstract
No abstracts available.